Genomic Health I Shares Up 43.8% Since SmarTrend's Buy Recommendation (GHDX)

SmarTrend identified an Uptrend for Genomic Health I (NASDAQ:GHDX) on May 7th, 2018 at $35.33. In approximately 1 month, Genomic Health I has returned 43.82% as of today's recent...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.